Literature DB >> 22613759

Comparison of the levels of the growth factors in umbilical cord serum and human milk and its clinical significance.

Satish Patki1, Ujjwala Patki, Rajendra Patil, S Indumathi, Pankaj Kaingade, Akshata Bulbule, Amar Nikam, Amit Pishte.   

Abstract

The process of the growth of the fetus begins in the uterus and gets further accelerated following the birth, especially during initial few months. The role of the growth factors in the physiology of the cellular growth is already well established. Vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) seem to be imperative for angiogenesis, cell development and proliferation as well as maintenance of the tissues. The levels of these factors in the maternal serum during pregnancy as well as during postpartum period are insignificant. Consequently, we hypothesized that the fetus receives moderate supply of these growth factors from the placenta during its stay in the uterus. This supply gets further augmented during the postpartum period through the different source, i.e. mother's milk. To study this physiological transition of the source of the growth factors from the placenta to the breast milk, the concentrations of VEGF and HGF in the cord serum of full term neonates and that in the breast milk of the corresponding mothers were analyzed during ELISA. The human milk, especially the colostrum revealed significantly higher levels of VEGF and HGF (1541.759 ± 119.349 pg/ml and 7129.249 ± 273.472 pg/ml) than cord serum (16.632 ± 0.773 pg/ml and 2581.6 ± 108.275 pg/ml) respectively. The multifold higher levels of VEGF observed in colostrum probably correlates with its high neonatal requirement for the maturation of the gastrointestinal epithelium following birth. The higher levels of both the growth factors in the breast milk than those observed in the cord serum probably explain their higher needs by the neonates for immunological protection, protein synthesis and neurocognitive development. The observations of the present study strengthen the policy of the colostrum feeding, which is promoted by organizations like World Health Organization (WHO). This study further documents the fact that the commercial milk formulae cannot replace the human milk.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613759     DOI: 10.1016/j.cyto.2012.04.010

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

Review 1.  Human Breast Milk: Bioactive Components, from Stem Cells to Health Outcomes.

Authors:  Flaminia Bardanzellu; Diego Giampietro Peroni; Vassilios Fanos
Journal:  Curr Nutr Rep       Date:  2020-03

Review 2.  Human milk composition: nutrients and bioactive factors.

Authors:  Olivia Ballard; Ardythe L Morrow
Journal:  Pediatr Clin North Am       Date:  2013-02       Impact factor: 3.278

Review 3.  Innate Immunity and Breast Milk.

Authors:  Nicole Theresa Cacho; Robert M Lawrence
Journal:  Front Immunol       Date:  2017-05-29       Impact factor: 7.561

4.  Levels of Growth Factors and IgA in the Colostrum of Women from Burundi and Italy.

Authors:  Daniel Munblit; Priya Abrol; Shreya Sheth; Li Yan Chow; Ekaterina Khaleva; Alan Asmanov; Silvana Lauriola; Ezio M Padovani; Pasquale Comberiati; Attilio L Boner; John O Warner; Robert J Boyle; Diego G Peroni
Journal:  Nutrients       Date:  2018-09-03       Impact factor: 5.717

5.  Therapeutic Effects and Repair Mechanism of HGF Gene-Transfected Mesenchymal Stem Cells on Injured Endometrium.

Authors:  Xuan Xu; Qiong Xing; Ruijun Liu; Liu Dong; Zhen Yu; Ying Wang; Ping Zhou; Ying V Zhang; Jianye Wang; Yunxia Cao; Zhaolian Wei
Journal:  Stem Cells Int       Date:  2022-04-05       Impact factor: 5.443

6.  Temporal development of the infant gut microbiome.

Authors:  Rebecca E Moore; Steven D Townsend
Journal:  Open Biol       Date:  2019-09-11       Impact factor: 6.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.